《新股消息》心通醫療(02160.HK):市場滲透率低 行業具增長空間
心通醫療(02160.HK)董事會主席羅七一表示,相較西方國家,目前中國內地的心臟介入式治療仍處於早期階段,受醫療器械普及程度、醫生經驗及合資格醫院數量不足等因素限制,經導管主動脈瓣植入術手術滲透率仍然很低,大部分僅限一、二線城市的一線心臟病醫院使用,因此未來市場發展空間龐大。
副總裁吳國佳補充,隨著內地疫情好轉,加上醫生培訓及市場教育逐漸加強,預期公司銷售額可錄得較大增幅。問到派息政策,財務總監倪暖表示現階段未能透露,但相信不久將來公司可望實現盈利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.